Acadia Healthcare Company, Inc. reported second quarter 2026 financial results on July 28, 2026. Total revenue was $865.8 million, flat year-over-year, while net income attributable to Acadia fell 64% to $10.9 million, or $0.12 per diluted share, compared to $30.1 million in the prior year. Adjusted EBITDA declined 26% to $149.2 million, impacted by a $28.6 million adjustment to professional and general liability reserves. The company added 240 licensed beds through new joint venture facilities in Florida and Iowa. Acadia updated its full-year 2026 guidance, raising the revenue range to $3.40–$3.45 billion and adjusted EBITDA to $590–$615 million. The company operates acute inpatient psychiatric facilities, specialty treatment centers, and residential treatment centers providing behavioral healthcare services across the United States and Puerto Rico.